At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 16 enrolled
Drug / intervention
Vareniclinedrug
Likely dose
Varenicline 1mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Open Label Study To Investigate The Feasibility And Efficacy Of A Smoking Cessation Program With Varenicline In Patients Undergoing Elective Surgery
In Brief
A Phase 4 clinical trial evaluating Varenicline for Smoking Cessation. Completed, enrolled 16 participants across 2 sites in 2 countries.
Detailed Summary
It is possible to offer smoking cessation treatment including varenicline to patients scheduled for elective surgery. This study will evaluate whether or not this will enable some patients to quit smoking for up to 4 weeks prior to surgery and in turn, whether this may lead to reductions in post-operative complication such as wound infections.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesFrance, Italy
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2009
Enrollment StartNov 2009
Primary CompletionJul 2010
TodayJul 2026
First PostedApr 29, 2009
Enrollment StartNov 1, 2009
Primary CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.2 years ago
Interventions
Vareniclinedrug
Varenicline film coated tablets - escalating dose with maximum dose of 1mg bd